Montserrat M. C.
- Country
- Spain
- Department
- Internal medicine
Research Overview
- Open-label extension study of KL1333 for long-term safety, tolerability, and efficacy in adults with primary mitochondrial disease
- Efficacy and Safety Evaluation of Leriglitazone in Adult Males with Cerebral Adrenoleukodystrophy: A Randomized, Placebo-Controlled Clinical Trial
- Safety and Efficacy Evaluation of Intravenous GLM101 in Patients with PMM2-CDG: A Phase 2 Open-Label Extension Study
Data & Insights
Has run more than one trial at 10 of 37 partner sites.
Specializations
Oncology – Advanced Solid Tumors
Focuses on therapeutic strategies for advanced solid tumors across multiple organ systems.
- Lung carcinoma
- Breast carcinoma
- Colorectal carcinoma
- Renal cell carcinoma
- Hepatocellular carcinoma
Emphasizes biomarker‑driven approaches and resistance mechanisms.
Hematology – Myeloid and Lymphoid Malignancies
Investigates treatment modalities for hematologic malignancies including acute and chronic leukemias and lymphomas.
- Acute myeloid leukemia
- Myelodysplastic syndromes
- Chronic lymphocytic leukemia
- Mantle cell lymphoma
- Multiple myeloma
Highlights integration of targeted agents and immunotherapies.
Respiratory Medicine – Sleep Apnea and Severe Asthma
Dedicated to management of moderate to severe obstructive sleep apnea and severe asthma in high‑risk populations.
- Obstructive sleep apnea
- Severe eosinophilic asthma
- Bronchiectasis
- Chronic obstructive pulmonary disease
- Acute respiratory distress syndrome
Uses phenotypic profiling to guide biologic selection.
Autoimmune & Inflammatory Diseases
Addresses therapeutic needs in systemic lupus erythematosus, psoriatic arthritis and inflammatory bowel disease.
- Systemic lupus erythematosus
- Psoriatic arthritis
- Crohn’s disease
- Ulcerative colitis
- Atopic dermatitis
Focuses on cytokine inhibition and personalized immunomodulation.
Infectious Diseases & Critical Care
Engages in clinical evaluation of interventions for COVID-19 and severe bacterial infections in critical settings.
- COVID-19
- Hospital‑acquired pneumonia
- Septic shock
- Acute bacterial skin infections
- Ventilator‑associated pneumonia
Prioritizes rapid viral clearance and antimicrobial stewardship.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.